Skip to content

Medpace Holdings, Inc. MEDP Ratios & Valuation

FY'25FY'24FY'23FY'22
Profitability
Operating margin21.1%0.0pp21.2%+3.3pp17.9%-1.2pp19.1%+1.7pp
Net margin17.8%-1.3pp19.2%+4.2pp15%-1.8pp16.8%+0.9pp
EBITDA margin22.3%-0.3pp22.6%+3.3pp19.3%-1.4pp20.6%+1.4pp
Free cash flow margin26.9%-0.2pp27.1%+6.1pp21%-3.0pp24.1%+3.5pp
Returns
Return on equity70.2%+11.8pp58.4%-1.4pp59.8%+23.2pp36.6%+16.0pp
Return on assets22.1%+0.6pp21.5%+2.7pp18.8%+2.5pp16.3%+4.4pp
Return on invested capital220%+123pp96.9%+42.6pp54.3%+14.2pp40.1%+12.5pp
Efficiency
Asset turnover1.2×+0.1×1.1×-0.1×1.3×+0.3×+0.2×
Liquidity
Current ratio0.7×-0.2×0.9×+0.3×0.6×+0.2×0.4×-0.8×
Quick ratio0.7×-0.2×0.9×+0.3×0.6×+0.2×0.4×-0.8×
Cash ratio0.4×-0.2×0.6×+0.3×0.3×+0.2×-0.8×
Leverage
Debt-to-equity0.3×+0.1×0.2×-0.1×0.3×-0.2×0.5×+0.4×
Debt-to-assets0.1×0.0×0.1×0.0×0.1×-0.1×0.2×+0.1×
Net debt / EBITDA-0.6×+0.5×-1.1×-0.9×-0.2×-0.8×0.6×+2.0×
Interest coverage41.9×+24.0×17.9×
Per Share
Book value per share$15.55-39.7%$25.79+46.9%$17.55+53.0%$11.48-54.6%
Valuation
Market capitalization$15.82B+53.2%$10.33B+9.7%$9.42B+42.5%$6.61B-15.5%
Enterprise value$15.46B+57.7%$9.81B+5.0%$9.34B+37.6%$6.79B-9.6%
Price / earnings35.1×+9.5×25.5×-7.8×33.3×+6.4×26.9×-16.1×
Price / sales6.3×+1.4×4.9×-0.1×+0.5×4.5×-2.3×
Price / book34.5×+22.0×12.5×-4.3×16.8×-0.3×17.1×+8.9×
EV / EBITDA27.5×+6.9×20.6×-5.1×25.7×+3.2×22.5×-11.6×
EV / sales6.1×+1.5×4.6×-0.3×+0.3×4.6×-1.9×
Free cash flow yield4.3%-1.2pp5.5%+1.3pp4.2%-1.1pp5.3%+2.3pp
Earnings yield2.9%-1.1pp3.9%+0.9pp3%-0.7pp3.7%+1.4pp
PEG ratio+2.4×0.6×-1.6×2.2×+1.4×0.8×-0.9×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Medpace Holdings, Inc.'s ratios come from?
Every ratio is computed from Medpace Holdings, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.